Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”
Marc‐Oliver Grimm(Klinik und Poliklinik für Urologie), E. Mumperow, Sarah Bos, Mario W. Kramer(Klinikum Lüneburg), Jörg Klier, Thomas Pulte, Harm H.E. van Melick(St. Antonius Ziekenhuis), Holger Schreier, Anders Bjartell(Lund University), Luis Martínez‐Piñeiro(Hospital Universitario La Paz), Marc Colombel(Hôpital Edouard Herriot), Christien Caris(European Association of Urology), E. Boven, Jan Marin, Dirk Zaak, Joan Palou(Universitat Autònoma de Barcelona), Richard P. Meijer(Unknown), Tim Muilwijk(KU Leuven), Michael Stephan-Odenthal, S. Machtens, Antoine G. van der Heijden(Radboud University Nijmegen), Bernd J. Schmitz‐Dräger, Andreas Schneider, Gerd Rodemer, Marie L. De Bruin(Utrecht University), Eva Hellmis, Anup Patel, Jörg Horstmann, Manfred P. Wirth(University Hospital Carl Gustav Carus), Wim P.J. Witjes(European Association of Urology), T. De Reijke, R. van Moorselaar(Amsterdam University Medical Centers), Roger Zillmann, T. Werner, Raymond G. Schipper(European Association of Urology), Joost L. Boormans(Erasmus MC), Georgios Gakis(University Hospital in Halle), Spiegelhalder, Andreas Al Ghazal, Levent N. Türkeri(Acıbadem University), Robert H. Rudolph, Marko Babjuk(Charles University), Wolfgang Rulf, Bart P. Wijsman, Theodor Klotz, Michael Siebels, H. Suttmann
Cited by 132
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
|The Lancet|2012|864
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793